ALPA — Alpa Laboratories Share Price
0.000.00%
Last trade - 00:00- IN₹2.54bn
- IN₹1.46bn
- IN₹1.09bn
- 63
- 40
- 88
- 75
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.54 | ||
| Price to Tang. Book | 1.54 | ||
| Price to Free Cashflow | 65.13 | ||
| Price to Sales | 2.61 | ||
| EV to EBITDA | 14.88 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 4.51% | ||
| Return on Equity | 13.53% | ||
| Operating Margin | 7.74% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 859.69 | 975.54 | 1,122.66 | 929.55 | 1,087.39 | n/a | n/a | 6.87% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +83.2 | +291.01 | +94.45 | -10.71 | +33.33 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Alpa Laboratories Limited is an India-based company, which is engaged in manufacturing and selling pharmaceutical finished dosage forms. The Company’s product range includes a wide variety of ethical, generic, and over the counter (OTC) drugs in various finished dosage forms for both human and veterinary use. Its human use products include capsules, such as Ampicillin Capsule IP/BP, Amoxycillin Trihydrate Capsule IP/BP, Cloxacillin Capsules IP/BP and Piroxicam Capsules IP BP; creams, gels and ointments, which include Lidocaine Hydrochloride Jelly IP/USP, Nitrofurazone Cream USP, Miconazole Cream IP/BP and Clobetasole Ointment/Cream BP; ear and eye drops, such as Benzylpenicillin Inj. IP/BP and Benzathine Penicillin Inj. IP/BP, and tablets, such as Ciprofloxacin Tablet IP / BP, Paracetamol Tablet IP/BP and Tinidazole Tablets IP/BP. Its veterinary products include boluses, such as Alpamin Bolus, Melovin-P Bolus and Alpazole Bolus, and injections, such as Atropine Inj. B.Vet.C and others.
Directors
- Purushottam Patel CHM (80)
- Jayesh Patel CEO
- Bakulesh Shah CFO
- Swati Bagh CCO (28)
- Paresh Chawla MDR
- Mahendra Chawla EDR (70)
- Pravin Shah EDR (65)
- Shashi Jain DRC
- Devendra Baheti NID (57)
- Jyoti Jain NID
- Sharad Lunawat NID
- Krishna Malani NID (65)
- Last Annual
- March 31st, 2024
- Last Interim
- September 30th, 2024
- Incorporated
- March 18th, 1988
- Public Since
- August 1st, 2007
- No. of Shareholders
- 18,980
- No. of Employees
- 410
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 21,040,600
- Address
- 33/2 Pigdamber, A.B. Road, Rau, INDORE, 453446
- Web
- http://www.alpalabs.in/
- Phone
- +91 7314294567
- Auditors
- C.H.Padilya & Co.
Upcoming Events for ALPA
Q4 2025 Alpa Laboratories Ltd Earnings Release
Similar to ALPA
Aarey Drugs and Pharmaceuticals
National Stock Exchange of India
Aarti Drugs
National Stock Exchange of India
Aarti Pharmalabs
National Stock Exchange of India
Abbott India
National Stock Exchange of India
Accent Microcell
National Stock Exchange of India
FAQ
What is the Alpa Laboratories share price?
As of Today at 18:11 UTC, shares in Alpa Laboratories are trading at IN₹120.71. This share price information is delayed by 15 minutes.
How has the Alpa Laboratories share price performed this year?
Shares in Alpa Laboratories last closed at IN₹120.71 and the price had moved by +24.64% over the past 365 days. In terms of relative price strength the Alpa Laboratories share price has outperformed the S&P BSE 100 Index by +2.45% over the past year.
What are the analyst and broker recommendations for Alpa Laboratories?
The overall consensus recommendation for Alpa Laboratories is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Alpa Laboratories dividend yield?
Alpa Laboratories does not currently pay a dividend.
Does Alpa Laboratories pay a dividend?
Alpa Laboratories does not currently pay a dividend.
When does Alpa Laboratories next pay dividends?
Alpa Laboratories does not currently pay a dividend.
How do I buy Alpa Laboratories shares?
To buy shares in Alpa Laboratories you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Alpa Laboratories?
As of the previous close price of IN₹120.71, shares in Alpa Laboratories had a market capitalisation of IN₹2.54bn.
Where are Alpa Laboratories shares listed?
Here are the trading details for Alpa Laboratories:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: ALPA
What kind of share is Alpa Laboratories?
Based on an overall assessment of its quality, value and momentum Alpa Laboratories is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Alpa Laboratories share price forecast for 2024?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Alpa Laboratories share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Alpa Laboratories. Over the past six months, its share price has outperformed the S&P BSE 100 Index by +35.64%.
As of the last closing price of IN₹120.71, shares in Alpa Laboratories were trading +20.45% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Alpa Laboratories PE Ratio?
The Alpa Laboratories PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹120.71.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Alpa Laboratories?
Alpa Laboratories' management team is headed by:
- Purushottam Patel - CHM
- Jayesh Patel - CEO
- Bakulesh Shah - CFO
- Swati Bagh - CCO
- Paresh Chawla - MDR
- Mahendra Chawla - EDR
- Pravin Shah - EDR
- Shashi Jain - DRC
- Devendra Baheti - NID
- Jyoti Jain - NID
- Sharad Lunawat - NID
- Krishna Malani - NID